| Entry |
|
|---|
| Name |
Methotrexate sodium;
Trexall (TN);
Rasuvo (TN)
|
|---|
| Product |
|
|---|
| Generic |
METHOTREXATE (Amneal Pharmaceuticals NY LLC), METHOTREXATE (Aurobindo Pharma Limited), METHOTREXATE (AvKARE), METHOTREXATE (Bryant Ranch Prepack), METHOTREXATE (Bryant Ranch Prepack), METHOTREXATE (Golden State Medical Supply), METHOTREXATE (Mylan Institutional), METHOTREXATE (Mylan Institutional LLC), METHOTREXATE (Mylan Pharmaceuticals), METHOTREXATE (PD-Rx Pharmaceuticals), METHOTREXATE (REMEDYREPACK), METHOTREXATE (Teva Parenteral Medicines), METHOTREXATE (Teva Parenteral Medicines), METHOTREXATE (Teva Pharmaceuticals USA), TREXALL (Teva Women's Health), METHOTREXATE (A-S Medication Solutions), METHOTREXATE (Fresenius Kabi USA), METHOTREXATE (Fresenius Kabi USA), METHOTREXATE SODIUM (REMEDYREPACK), METHOTREXATE (Sun Pharmaceutical Industries), METHOTREXATE SODIUM (West-Ward Pharmaceuticals Corp.) |
|---|
| Formula |
C20H21N8O5. Na
|
|---|
| Exact mass |
476.1533
|
|---|
| Mol weight |
476.4211
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antineoplastic
DG01930 Dihydrofolate reductase inhibitor, antineoplastic
DG01978 Folic acid analog
DG01930 Dihydrofolate reductase inhibitor, antineoplastic
DG02018 Antimetabolite
DG01978 Folic acid analog
DG01930 Dihydrofolate reductase inhibitor, antineoplastic
Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drugs (DMARDs)
|
|---|
| Remark |
| Product (DG00681): | D00142<JP/US> D02115<US> |
|
|---|
| Efficacy |
Antineoplastic, Antimetabolite |
|---|
| Disease |
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07041 | Antineoplastics - antimetabolic agents |
| map07050 | Antirheumatics - DMARDs and biological agents |
|
|---|
| Other map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BA Folic acid analogues
L01BA01 Methotrexate
D02115 Methotrexate sodium <US>
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AX Other immunosuppressants
L04AX03 Methotrexate
D02115 Methotrexate sodium <US>
USP drug classification [BR:br08302]
Antineoplastics
Antineoplastics, Other
Methotrexate
D02115 Methotrexate sodium
Immunological Agents
Immunosuppressants
Antimetabolites, Antiproliferative
Methotrexate
D02115 Methotrexate sodium
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Dihydrofolate reductase
DHFR
D02115 Methotrexate sodium <US>
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 34
1 C8y C 23.0300 -14.3500
2 N5x N 23.0300 -15.7500
3 C8y C 24.2900 -16.4500
4 C8y C 25.4800 -15.7500
5 C8y C 25.4800 -14.3500
6 N5x N 24.2900 -13.6500
7 N5x N 26.7400 -16.4500
8 C8y C 27.9300 -15.7500
9 C8x C 27.9300 -14.3500
10 N5x N 26.7400 -13.6500
11 N1a N 21.8400 -13.6500
12 N1a N 24.2900 -17.8500
13 C1b C 29.1200 -16.4500
14 N1c N 30.3100 -15.7500
15 C8y C 31.5000 -16.4500
16 C1a C 30.3100 -14.3500
17 C8x C 31.5000 -17.8500
18 C8x C 32.7600 -18.5500
19 C8y C 33.9500 -17.8500
20 C8x C 33.9500 -16.4500
21 C8x C 32.7600 -15.7500
22 C5a C 35.1400 -18.5500
23 N1b N 36.4000 -17.8500
24 O5a O 35.1400 -19.9500
25 C1c C 37.5900 -18.5500
26 C1b C 38.7800 -17.8500
27 C1b C 39.9700 -18.5500
28 C6a C 41.1600 -17.8500
29 O6a O 42.3500 -18.5500 #-
30 C6a C 37.5900 -19.9500
31 O6a O 38.7800 -20.6500
32 O6a O 36.3300 -20.6500
33 O6a O 41.1600 -16.4500
34 Z Na 43.9600 -18.6200 #+
BOND 35
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 5 10 1
12 1 11 1
13 3 12 1
14 8 13 1
15 13 14 1
16 14 15 1
17 14 16 1
18 15 17 2
19 17 18 1
20 18 19 2
21 19 20 1
22 20 21 2
23 15 21 1
24 19 22 1
25 22 23 1
26 22 24 2
27 23 25 1
28 25 26 1
29 26 27 1
30 27 28 1
31 28 29 1
32 25 30 1 #Up
33 30 31 1
34 30 32 2
35 28 33 2
|
|---|
